Alchemia/Dr Reddy's launch cut-price generic Arixtra in India
This article was originally published in Scrip
Executive Summary
Australia's Alchemia and its Indian commercialisation partner, Dr Reddy's Laboratories, have launched their cut-price generic anticoagulant fondaparinux in India - the first market outside the US since its 2011 launch there.